How quickly blood albumin returns after major liver, pancreas, or bile-duct surgery predicts recovery
Official title: Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries
Run by Institute of Liver and Biliary Sciences, India · NCT07263061 · Data updated 2026-11-12
This study will see if the speed at which serum albumin returns after major hepato‑pancreato‑biliary surgery predicts complications and hospital stay for patients aged 12 and up.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 13 Years to 80 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Institute of Liver and Biliary Sciences, India Academic / other |
| Locations | 1 site (New Delhi, National Capital Territory of Delhi) |
| Status | Recruiting |
| Started | December 7, 2025 |
| Main results expected | October 23, 2026 |
| Study ends | October 23, 2026 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT07263061 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged over 12 undergoing planned major hepato‑pancreato‑biliary (liver, pancreas, or bile duct) surgery at the enrolling center who can provide consent.
✕Probably not a fit
Patients with chronic liver disease, nephrotic syndrome, protein‑losing enteropathies, inflammatory bowel disease, those undergoing emergency surgery, or those unable/unwilling to consent are excluded and unlikely to benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort that combines a retrospective arm (data from 2010 onward) with contemporaneous data collection at a single tertiary hepatobiliary center. Investigators will track perioperative serum albumin levels and record the time until albumin recovers toward baseline or a predefined threshold. They will compare that recovery time with post‑operative outcomes such as complications, morbidity, and length of hospital stay while accounting for factors like fluid management and albumin supplementation. The goal is to determine whether earlier albumin recovery is associated with lower complication rates and shorter admissions.
Why it matters
Potential benefit: If successful, the approach could help clinicians identify patients at higher risk of complications earlier and tailor monitoring or interventions to shorten recovery and hospital stay.
How similar studies have gone: Prior observational work has linked low perioperative albumin with worse outcomes, but contemporary data specifically using the time to albumin recovery as a prognostic marker are sparse and relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients undergoing major Hepato pancreatico Biliary surgeries. 2. Patients who are more than 12 years of age 3. Retrospective arm - Data from 2010 Exclusion Criteria: 1. Patients who refuse or are unable to give consent. 2. Patients with Nephrotic syndrome, Protein losing enteropathies, Inflammatory bowel 3. Disease, Chronic Liver Disease. 4. Emergency Surgeries
Where it's running
-
Ilbs
New Delhi, National Capital Territory of Delhi, India Recruiting
Study contacts
- Study coordinator: Dr Rajagopalan G, DNB
- Email: prash1108@gmail.com
- Phone: 8220408324
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating outcomes of hepatobiliopancreatic surgery
This study looks at the health outcomes and survival rates of patients who have had surgery for liver, bile duct, or pancreas issues to see how well they do after the operation.
-
Rectal indomethacin plus cold-water ampullary cooling to lower pancreatitis after ERCP
This will test whether adding cold-water cooling of the ampulla to standard rectal indomethacin lowers the chance of pancreatitis in adults having ERCP.
-
Using artificial intelligence to improve endoscopic ultrasound for pancreatic diseases
This study is testing whether an artificial intelligence system can help doctors find problems in the pancreas during ultrasound exams to improve diagnosis and reduce mistakes.
-
Comparing two methods for examining gastrointestinal lesions
This study is testing whether a new imaging system for examining gastrointestinal lesions works better than the standard method for people undergoing endoscopic ultrasound.
-
Comparing two techniques for bile duct access during ERCP
This study is testing whether a new technique using endoscopic ultrasound is better than a standard method for helping patients with difficult bile duct access during a procedure called ERCP.
-
Registry collecting radiological data on pancreatic cancer
This study is collecting medical imaging data from patients with pancreatic cancer to see how their condition progresses and how well they respond to treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.